Dashboard
Manage Tickers

EWEdwards Lifesciences Corp

NYSE edwards.com


$ 69.79 $ 0.96 (1.39 %)    

Monday, 16-Sep-2024 11:10:29 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 471.12 $ -1.94 (-0.41 %)
DIA $ 416.29 $ 1.35 (0.33 %)
SPY $ 561.07 $ -0.40 (-0.07 %)
TLT $ 100.93 $ 0.30 (0.3 %)
GLD $ 238.45 $ -0.15 (-0.06 %)
$ 68.52
$ 68.83
$ 69.77 x 100
$ 70.50 x 1,500
$ 68.77 - $ 69.79
$ 58.93 - $ 96.12
11,862,886
na
41.28B
$ 1.18
$ 28.02
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-31-2024 06-30-2024 10-Q
2 04-29-2024 03-31-2024 10-Q
3 02-12-2024 12-31-2023 10-K
4 10-27-2023 09-30-2023 10-Q
5 07-28-2023 06-30-2023 10-Q
6 04-28-2023 03-31-2023 10-Q
7 02-13-2023 12-31-2022 10-K
8 10-28-2022 09-30-2022 10-Q
9 07-29-2022 06-30-2022 10-Q
10 04-28-2022 03-31-2022 10-Q
11 02-14-2022 12-31-2021 10-K
12 10-29-2021 09-30-2021 10-Q
13 07-30-2021 06-30-2021 10-Q
14 04-28-2021 03-31-2021 10-Q
15 02-12-2021 12-31-2020 10-K
16 10-26-2020 09-30-2020 10-Q
17 07-27-2020 06-30-2020 10-Q
18 04-28-2020 03-31-2020 10-Q
19 02-14-2020 12-31-2019 10-K
20 10-25-2019 09-30-2019 10-Q
21 07-26-2019 06-30-2019 10-Q
22 04-26-2019 03-31-2019 10-Q
23 02-15-2019 12-31-2018 10-K
24 10-26-2018 09-30-2018 10-Q
25 07-27-2018 06-30-2018 10-Q
26 04-27-2018 03-31-2018 10-Q
27 02-16-2018 12-31-2017 10-K
28 10-27-2017 09-30-2017 10-Q
29 07-28-2017 06-30-2017 10-Q
30 04-28-2017 03-31-2017 10-Q
31 02-17-2017 12-31-2016 10-K
32 10-28-2016 09-30-2016 10-Q
33 07-29-2016 06-30-2016 10-Q
34 04-29-2016 03-31-2016 10-Q
35 02-19-2016 12-31-2015 10-K
36 10-29-2015 09-30-2015 10-Q
37 07-29-2015 06-30-2015 10-Q
38 04-29-2015 03-31-2015 10-Q
39 02-20-2015 12-31-2014 10-K
40 10-31-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

truist-securities-maintains-hold-on-edwards-lifesciences-lowers-price-target-to-71
Truist Securities Maintains Hold on Edward...
09/13/2024 14:55:10

Truist Securities analyst Richard Newitter maintains Edwards Lifesciences (NYSE:EW) with a Hold and lowers the price target ...

oppenheimer-maintains-outperform-on-edwards-lifesciences-maintains-90-price-target
Oppenheimer Maintains Outperform on Edward...
09/12/2024 14:25:14

Oppenheimer analyst Suraj Kalia maintains Edwards Lifesciences (NYSE:EW) with a Outperform and maintains $90 price target.

ubs-maintains-neutral-on-edwards-lifesciences-lowers-price-target-to-75
UBS Maintains Neutral on Edwards Lifescien...
09/10/2024 13:23:25

UBS analyst Danielle Antalffy maintains Edwards Lifesciences (NYSE:EW) with a Neutral and lowers the price target from $90 t...

barclays-maintains-overweight-on-edwards-lifesciences-lowers-price-target-to-80
Barclays Maintains Overweight on Edwards L...
09/09/2024 18:40:47

Barclays analyst Matt Miksic maintains Edwards Lifesciences (NYSE:EW) with a Overweight and lowers the price target from $90...

analyst-scoreboard-19-ratings-for-edwards-lifesciences
Analyst Scoreboard: 19 Ratings For Edwards...
09/09/2024 14:01:05

wells-fargo-maintains-overweight-on-edwards-lifesciences-lowers-price-target-to-80
Wells Fargo Maintains Overweight on Edward...
09/09/2024 13:30:21

Wells Fargo analyst Larry Biegelsen maintains Edwards Lifesciences (NYSE:EW) with a Overweight and lowers the price target f...

edwards-lifesciences-completes-42b-sale-of-critical-care-to-bd-announces-1b-share-repurchase-and-board-authorizes-additional-15b-for-future-buybacks
Edwards Lifesciences Completes $4.2B Sale ...
09/03/2024 20:34:00

- SEC Filing

reported-earlier-edwards-lifesciences-rheia-trial-discloses-tavi-outcomes-for-women-with-sapien-3-valves
Reported Earlier, Edwards Lifesciences RHE...
09/03/2024 07:31:45

Edwards Lifesciences (NYSE:EW) today announced the results from the RHEIA Trial, a first-of-its-kind trial focused exclusively ...

peering-into-edwards-lifesciencess-recent-short-interest
Peering Into Edwards Lifesciences's Recent...
08/30/2024 17:00:14

9-health-care-stocks-whale-activity-in-todays-session
9 Health Care Stocks Whale Activity In Tod...
08/13/2024 17:35:23

heres-how-much-100-invested-in-edwards-lifesciences-15-years-ago-would-be-worth-today
Here's How Much $100 Invested In Edwards L...
08/06/2024 16:00:16

top-3-health-care-stocks-that-are-set-to-fly-this-quarter
Top 3 Health Care Stocks That Are Set To F...
08/01/2024 13:16:41

jim-cramer-says-this-home-improvement-chain-is-a-buy-ahead-of-fed-rate-cut-cycle-i-would-pick-some-up-tomorrow
Jim Cramer Says This Home Improvement Chai...
07/31/2024 13:08:49

Jim Cramer recommends buying Blackstone Inc. (BX) due to its strong companies and expects Lowe's (LOW) stock to benefit fro...

top-3-health-care-stocks-that-may-explode-in-q3
Top 3 Health Care Stocks That May Explode ...
07/31/2024 11:35:49

how-is-the-market-feeling-about-edwards-lifesciences
How Is The Market Feeling About Edwards Li...
07/30/2024 16:00:19

if-you-invested-100-in-this-stock-20-years-ago-you-would-have-2200-today
If You Invested $100 In This Stock 20 Year...
07/29/2024 17:32:23

what-22-analyst-ratings-have-to-say-about-edwards-lifesciences
What 22 Analyst Ratings Have To Say About ...
07/29/2024 12:01:23

wolfe-research-upgrades-edwards-lifesciences-to-peer-perform
Wolfe Research Upgrades Edwards Lifescienc...
07/29/2024 10:47:39

Wolfe Research analyst Mike Polark upgrades Edwards Lifesciences (NYSE:EW) from Underperform to Peer Perform.

ford-stellantis-and-dell-are-among-top-12-large-cap-losers-last-week-july-21-july-27-are-the-others-in-your-portfolio
Ford, Stellantis And Dell Are Among Top 12...
07/28/2024 17:58:18

Top 10 worst performers last week: EW (-28.05%), F (-19.12%), STM (-17.60%), TER (-16.25%), MBLY (-14.61%), STLA (-13.07%), VRT...

market-whales-and-their-recent-bets-on-edwards-lifesciences-options
Market Whales and Their Recent Bets on Edw...
07/26/2024 17:01:10

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION